The Biomarker Guide: What to Test, What It Means, and What to Do About It

Most people have had blood work done, been told everything looks “normal,” and still feel tired, foggy, inflamed, or just “off.” The problem is not always the test itself; it’s what gets tested and how those results are interpreted. Standard lab ranges are designed to detect diseases across a population, not necessarily to identify whether your body is functioning at its best. 

The gap between “normal” and “optimal” is where many early health problems begin. This guide covers the biomarkers that matter for men and women, and what to do when they are off.

What is a Biomarker?

A biomarker is a measurable signal in your body, usually found through blood, saliva, urine, or wearable data, that helps reveal how a biological system is functioning. Biomarkers can show patterns in metabolism, hormones, inflammation, cardiovascular risk, organ function, nutrient status, and recovery capacity¹.

Most standard lab panels use population-based reference ranges designed to identify disease, not optimize performance. That means a result can fall inside the “normal” range while still being far from ideal for you. 

This guide focuses on the biomarkers that matter most, including specific optimal ranges where appropriate, so you can understand not just whether you are clinically “fine,” but whether your body is functioning at its best.

Biomarkers Everyone Should Track

Metabolic Health & Insulin Function

Fasting insulin

One of the earliest warning signals of metabolic dysfunction, fasting insulin is skipped on most standard panels; an optimal range is often closer to 2–5 µIU/mL, even though many labs allow “normal” up to 25². 

HbA1c + fasting glucose

HbA1c shows average blood sugar over roughly three months, while fasting glucose gives a point-in-time snapshot; together, they map metabolic health beyond basic diabetes screening³. 

HOMA-IR

Calculated from fasting insulin and fasting glucose, HOMA-IR helps quantify insulin resistance before symptoms or abnormal glucose levels appear⁴. 

Cardiovascular & Heart Health

ApoB 

ApoB counts the number of atherogenic particles in circulation, making it a stronger cardiovascular risk marker than LDL cholesterol alone⁵. 

Lp(a)

Lp(a) is an inherited cardiovascular risk factor present in roughly 1 in 5 people; it is not included on standard panels, should be tested at least once, and typically does not change much with lifestyle⁶. 

hsCRP 

High-sensitivity C-reactive protein measures chronic inflammation load, a major driver of cardiovascular aging and long-term disease risk⁷. 

Inflammation & Organ Health

Ferritin 

Ferritin reflects iron storage but can also rise with inflammation; optimal ranges are often around 50–100 ng/mL for men, 30–70 ng/mL for premenopausal women, and 50–100 ng/mL for postmenopausal women^8,9. 

ALT/AST 

These liver enzymes can indicate liver stress, which is common in metabolic dysfunction, alcohol exposure, medication burden, and heavy training¹⁰. 

eGFR/creatinine

These markers estimate kidney filtration function, which can decline silently with age, hypertension, insulin resistance, and metabolic stress¹¹. 

Brain & Longevity Markers

Homocysteine 

Elevated homocysteine is associated with accelerated cardiovascular and cognitive aging and is rarely ordered on standard panels; an optimal target is often under 8 µmol/L¹². 

Vitamin D 

Vitamin D supports immune function, bone health, mood, and testosterone production; an optimal range is often 50–70 ng/mL, even though many labs consider levels above 20 sufficient¹³. 

Omega-3 index 

This measures EPA and DHA levels in red blood cells and may reflect cardiovascular and cognitive risk more accurately than simply tracking fish oil intake¹⁴.

Biomarkers that Matter Most for Men

Hormonal Health & Testosterone

Free testosterone 

Free testosterone is the bioavailable fraction that drives energy, libido, muscle maintenance, motivation, and mood; total testosterone can look “normal” while free testosterone is depleted^15,16. Optimal free testosterone is typically in the upper quartile for age. 

Sex hormone–binding globulin 

SHBG binds testosterone and makes it unavailable to tissues, which is why a man can have normal total testosterone but still experience symptoms of low testosterone if SHBG is high¹⁷. 

LH + FSH 

Luteinizing hormone and follicle-stimulating hormone are brain-to-testes signaling markers that help distinguish whether low testosterone is driven by testicular function, pituitary signaling, or broader hormonal suppression¹⁸. 

DHEA-S 

DHEA-S is an adrenal precursor hormone that declines with age and chronic stress and may influence energy, immune resilience, body composition, and overall vitality¹⁹. 

Metabolic Markers Men Miss

Cortisol, four-point salivary

A full cortisol curve shows the rhythm of stress output across the day, not just one serum snapshot; high-performing men may show low morning cortisol with elevated evening cortisol, a pattern commonly associated with burnout²⁰. 

PSA 

Prostate-specific antigen provides a baseline prostate health marker and is especially important before starting testosterone therapy; men with a family history may benefit from baseline testing around age 40–45²¹. 

Hematocrit/hemoglobin 

These markers reflect oxygen-carrying capacity and are critical for men on TRT, because levels can rise during therapy and may require protocol adjustment²². 

Why These Matter Together for Men

A man with low free testosterone, high SHBG, elevated fasting insulin, and rising hsCRP is not showing four unrelated lab abnormalities. He is showing a recognizable pattern: a metabolic and hormonal system under sustained load. The benefit of tracking these markers together is that each one is actionable, and the pattern tells a physician where to start.

Biomarkers that Matter Most for Women

Hormonal Transition Markers

FSH

FSH rises as ovarian reserve declines, although more signals are needed in tandem to determine when a woman is in the perimenopause-to-menopause transition²³. 

Estradiol 

Estradiol is the primary active estrogen, but it can fluctuate dramatically during perimenopause before declining; a single reading is only a snapshot, so trends over time matter more²⁴. 

Progesterone 

Progesterone is often the first hormone to decline in perimenopause, even before estrogen; low levels can contribute to sleep disruption, anxiety, irregular cycles, and PMS-like symptoms long before hot flashes begin²⁵. 

Testosterone 

Testosterone is frequently overlooked in women, but it supports libido, energy, motivation, muscle maintenance, and body composition; it often declines through the 40s and is rarely checked on standard panels²⁶. 

DHEA-S

DHEA-S is an adrenal androgen precursor that supports estrogen and testosterone production; low levels may contribute to fatigue, cognitive fog, low libido, and reduced resilience under stress²⁶. 

Thyroid: Critical and Frequently Missed

TSH + Free T3 + Free T4 

TSH alone is not the full thyroid picture; thyroid dysfunction is common during perimenopause and can look exactly like hormone imbalance, including fatigue, weight changes, brain fog, and mood disruption²⁷. 

Thyroid antibodies (TPO + TgAb)

Autoimmune thyroid disease is significantly more common in women and can go undiagnosed for years until pregnancy. Antibody testing can reveal early thyroid autoimmunity even when TSH appears normal²⁸. 

Cardiovascular Risk: The Post-Estrogen Shift

ApoB 

Cardiovascular risk accelerates after estrogen declines, and ApoB tracks atherogenic particle burden more accurately than LDL cholesterol alone; it should be part of every woman’s panel from perimenopause onward²⁹. 

Lp(a) 

Lp(a) may become more clinically important when estrogen is no longer protective; testing once can help inform prevention, HRT, and lipid-lowering decisions³⁰. 

hsCRP 

Inflammation often rises after menopause and contributes to cardiovascular and cognitive aging; hsCRP is an important baseline marker before and during hormone therapy^31,32. 

Metabolic Markers Women Miss

Fasting insulin + HOMA-IR

Insulin resistance risk increases during and after menopause, and many women gain weight or develop metabolic dysfunction during this transition despite no major change in diet or exercise³³. 

Ferritin 

Iron status can fluctuate significantly around perimenopause; heavy periods may drive depletion, while the transition to no periods can normalize or raise levels, making monitoring important through the transition³⁴. 

Cortisol curve 

Chronic stress competes with already-declining estrogen and progesterone, making the cortisol-sleep-hormone relationship especially important for women experiencing perimenopause worsened sleep³⁵. 

Why These Matter Together for Women

Perimenopause is not a single event. It is a hormonal transition that unfolds over years, affecting metabolism, cardiovascular risk, thyroid function, mood, cognition, sleep, and body composition at the same time.

The women who navigate this transition best are often the ones whose physicians are tracking the full picture, not just estrogen. A single hormone panel is a snapshot. The value is in the trend: how lab markers, insulin, inflammation, and cardiovascular risk shift together over time.

Normal vs Optimal: Why the Gap Matters

Standard lab ranges are built to flag disease across a broad population. They are useful for identifying when something is clearly abnormal, but they often miss the earlier window where your body is already showing signs of stress, dysfunction, or declining performance.

Optimal ranges are different. They are designed to help answer a more useful question: Is this marker where it should be for long-term resilience?

Biomarker	Lab 'Normal'  →  Opt Optimal
Fasting insulin	< 25 µIU/mL  →  2–5 µIU/mL
Ferritin (men)	> 12 ng/mL  →  50–100 ng/mL
Ferritin (women pre-meno)	> 12 ng/mL  →  30–70 ng/mL
Vitamin D	> 20 ng/mL  →  50–70 ng/mL
Free testosterone (men)	Within range  →  Upper quartile for age
hsCRP	< 3.0 mg/L  →  < 0.5 mg/L (optimal)
Homocysteine	< 15 µmol/L  →  < 8 µmol/L

This gap matters because many people do not feel their best long before they qualify for a diagnosis. A fasting insulin of 18 may be “normal,” but it can still suggest that the body is working too hard to maintain blood sugar control. A vitamin D level of 24 may be “sufficient,” but it may not be optimal for immune function, mood, hormone production, or bone health.

At Opt Health, the goal is not to chase perfect numbers, but it is to interpret biomarkers in context. That is where lab testing becomes actionable.

How Often Should You Test?

Start with a baseline panel. You cannot optimize what you have not measured, and a single test gives your physician a starting point for understanding your current metabolic, hormonal, inflammatory, and cardiovascular status.

From there, retesting depends on what you are actively working to change. Many biomarkers should be retested every 3–6 months. This gives enough time to see whether the protocol is moving your biology in the right direction.

Hormonal markers may require closer monitoring during transition periods. Men starting or adjusting testosterone therapy often need repeat testing of free testosterone, SHBG, PSA, hematocrit, and estradiol. 

Women in perimenopause or menopause may need repeat testing of estradiol, progesterone, testosterone, FSH, thyroid markers, and inflammatory markers as symptoms and hormone levels change.

The goal is not to react to every single number; it is to identify trends. One lab result is a snapshot. Repeated testing shows the trajectory.

What Should You Do If Your Results Are Off?

When a biomarker is outside the optimal range, the next step is not to treat that number in isolation. A physician looks for patterns.

One marker off is a data point. Three related markers off is a pattern. That pattern is what drives a protocol.

For example, a slightly elevated fasting glucose may not explain much on its own. But fasting glucose combined with high fasting insulin, elevated HOMA-IR, rising triglycerides, and increased hsCRP suggests insulin resistance with inflammatory stress. That requires a different strategy than glucose alone.

The same is true for hormones. A man with “normal” total testosterone may still have low free testosterone if SHBG is high. A woman with fatigue and weight gain may not have a menopause problem alone; she may have low progesterone, declining testosterone, thyroid autoimmunity, and early insulin resistance all happening together.

This is why biomarker interpretation should be contextual. The right question is not simply, “Is this lab normal?” It is, “What is this marker telling us about the system as a whole, and what can we do to improve it?”

How Opt Approaches Biomarker Optimization

Getting a number is not the same as knowing what to do with it. An Opt physician tracks your labs over time alongside your symptoms, medical history, goals, medications, lifestyle, and how your biomarkers interact with each other.

From there, Opt builds a personalized protocol designed to move your markers toward optimal function, not just keep them inside broad reference ranges. 

That may include nutrition, exercise, sleep, supplements, hormone optimization, metabolic support, or ongoing monitoring. The goal is simple: turn lab data into a clear, physician-guided plan.

FAQs

What biomarkers should men over 40 track?

Men over 40 should track free testosterone, total testosterone, SHBG, LH, FSH, DHEA-S, fasting insulin, HOMA-IR, ApoB, Lp(a), hsCRP, PSA, hematocrit, vitamin D, homocysteine, and thyroid markers. 

These biomarkers help identify the patterns that most often drive low energy, declining muscle, reduced libido, weight gain, cardiovascular risk, and poor recovery.

What biomarkers should women track during perimenopause?

Women in perimenopause should track FSH, estradiol, progesterone, testosterone, DHEA-S, TSH, Free T3, Free T4, thyroid antibodies, fasting insulin, HOMA-IR, ApoB, Lp(a), hsCRP, ferritin, vitamin D, and cortisol rhythm. 

Perimenopause affects hormones, thyroid function, metabolism, sleep, cardiovascular risk, and mood at the same time, so testing only estrogen misses the bigger picture.

What blood tests does a standard physical miss?

A standard physical often includes a basic metabolic panel, CBC, lipid panel, and sometimes TSH or HbA1c. It commonly misses fasting insulin, HOMA-IR, ApoB, Lp(a), hsCRP, homocysteine, free testosterone, SHBG, full thyroid markers, thyroid antibodies, omega-3 index, and sex-specific hormone markers.

What is the difference between normal and optimal lab ranges?

Normal lab ranges are designed to flag disease across a broad population. Optimal ranges are narrower targets used to evaluate function, performance, prevention, and long-term health. 

A result can be “normal” and still be far from ideal for energy, metabolic health, hormone function, or cardiovascular risk.

What is the most important biomarker for men’s energy?

Free testosterone is one of the most important biomarkers for men’s energy because it reflects the testosterone available to tissues. 

However, it should not be interpreted alone. SHBG, cortisol rhythm, fasting insulin, thyroid markers, vitamin D, ferritin, and inflammation markers often explain why energy remains low even when total testosterone appears normal.

Why does my doctor not test fasting insulin or free testosterone?

Many standard medical visits are designed to screen for disease, not optimize function. Fasting glucose and HbA1c screen for diabetes, but fasting insulin can reveal insulin resistance much earlier. 

Total testosterone is often ordered because it is familiar, but free testosterone and SHBG provide a clearer picture of hormone availability.

What blood tests should women ask for that GPs rarely order?

Women should consider asking about fasting insulin, HOMA-IR, ApoB, Lp(a), hsCRP, ferritin, Free T3, Free T4, thyroid antibodies, progesterone, testosterone, DHEA-S, and vitamin D. 

These markers are especially useful during perimenopause, when symptoms can overlap across hormone, thyroid, metabolic, and inflammatory systems.

How often should I retest my biomarkers?

Most people should start with a baseline panel and retest every 3–6 months when actively changing something, such as nutrition, exercise, hormone therapy, weight loss medication, supplements, or cardiovascular risk management. Once stable, testing may be less frequent, but trend tracking remains more useful than a single snapshot.

Can biomarker testing help with fatigue, brain fog, and low energy?

Yes. Fatigue, brain fog, and low energy are often driven by patterns across multiple systems, including insulin resistance, low free testosterone, thyroid dysfunction, nutrient insufficiency, inflammation, poor cortisol rhythm, or low vitamin D. 

Biomarker testing helps identify which systems are under strain so a physician can build a targeted plan instead of guessing.

References

1. Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018;243(3):213-221. doi:10.1177/1535370217750088

2. Schrank Y, Fontes R, Perozo AFDF, et al. Proposal for fasting insulin and HOMA-IR reference intervals based on an extensive Brazilian laboratory database. Arch Endocrinol Metab. 2024;68:e230483. doi:10.20945/2359-4292-2023-0483

3. Eyth E, Zubair M, Naik R. Hemoglobin A1C. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK549816/

4. Horáková D, Štěpánek L, Janout V, et al. Optimal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Cut-Offs: A Cross-Sectional Study in the Czech Population. Medicina (Kaunas). 2019;55(5):158. doi:10.3390/medicina55050158

5. Devaraj S, Semaan JR, Jialal I. Biochemistry, Apolipoprotein B. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK538139/

6. Farzam K, Zubair M, Senthilkumaran S. Lipoprotein A. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK570621/

7. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439-493.

8. Liu JM, Hankinson SE, Stampfer MJ, Rifai N, Willett WC, Ma J. Body iron stores and their determinants in healthy postmenopausal US women2. The American Journal of Clinical Nutrition. 2003;78(6):1160-1167. doi:10.1093/ajcn/78.6.1160

9. What Is a Ferritin Test? Cleveland Clinic. Accessed May 20, 2026. https://my.clevelandclinic.org/health/diagnostics/17820-ferritin-test

10. Lala V, Zubair M, Minter DA. Liver Function Tests. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK482489/

11. Gounden V, Bhatt H, Jialal I. Renal Function Tests. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK507821/

12. Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017;14:78. doi:10.1186/s12986-017-0233-z

13. Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK441912/

14. Harris WS. Recent studies confirm the utility of the omega-3 index. Curr Opin Clin Nutr Metab Care. 2025;28(2):91-95. doi:10.1097/MCO.0000000000001078

15. Testosterone Therapy for Hypogonadism Guideline Resources. Accessed May 20, 2026. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy

16. Testosterone Deficiency Guideline - American Urological Association. Accessed May 20, 2026. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline

17. Li C, Ford ES, Li B, Giles WH, Liu S. Association of Testosterone and Sex Hormone–Binding Globulin With Metabolic Syndrome and Insulin Resistance in Men. Diabetes Care. 2010;33(7):1618-1624. doi:10.2337/dc09-1788

18. Babu SR, Sadhnani MD, Swarna M, Padmavathi P, Reddy PP. Evaluation of FSH, LH and testosterone levels in different subgroups of infertile males. Indian J Clin Biochem. 2004;19(1):45-49. doi:10.1007/BF02872388

19. Schooling CM, Zhao JV. Dehydroepiandrosterone sulfate on lifespan in men and women using Mendelian randomization. Nutr Metab Cardiovasc Dis. 2025;35(10):104128. doi:10.1016/j.numecd.2025.104128

20. Adam EK, Quinn ME, Tavernier R, McQuillan MT, Dahlke KA, Gilbert KE. Diurnal Cortisol Slopes and Mental and Physical Health Outcomes:A Systematic Review and Meta-analysis. Psychoneuroendocrinology. 2017;83:25-41. doi:10.1016/j.psyneuen.2017.05.018

21. David MK, Leslie SW. Prostate-Specific Antigen. In: StatPearls. StatPearls Publishing; 2026. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK557495/

22. Cervi A, Balitsky AK. Testosterone use causing erythrocytosis. CMAJ. 2017;189(41):E1286-E1288. doi:10.1503/cmaj.170683

23. Das S, Bhattacharya N, Mahata R, Ghosh S, Bhar AS, Srivastava P. Correlation of Follicle-stimulating Hormone, Anti-Mullerian Hormone, and Antral Follicle Count with Age in Ovarian Reserve Testing. Int J Appl Basic Med Res. 2024;14(3):162-168. doi:10.4103/ijabmr.ijabmr_81_24

24. Yu Z, Jiao Y, Zhao Y, Gu W. Level of Estrogen in Females—The Different Impacts at Different Life Stages. J Pers Med. 2022;12(12):1995. doi:10.3390/jpm12121995

25. Motlani V, Motlani G, Pamnani S, Sahu A, Acharya N. Endocrine Changes in Postmenopausal Women: A Comprehensive View. Cureus. 15(12):e51287. doi:10.7759/cureus.51287

26. Wang Y, Islam RM, Bond M, Davis SR. Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study. eBioMedicine. 2025;121:105972. doi:10.1016/j.ebiom.2025.105972

27. Kim MI, Bertot BE. Hypothyroidism in Older Adults. In: Feingold KR, Adler RA, Ahmed SF, et al., eds. Endotext. MDText.com, Inc.; 2000. Accessed May 20, 2026. http://www.ncbi.nlm.nih.gov/books/NBK279005/

28. Andersen SL, Bruun NH, Christensen PA, et al. Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancy. Eur Thyroid J. 2022;11(6):e220142. doi:10.1530/ETJ-22-0142

29. Faraj M, Messier L, Bastard JP, et al. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia. 2006;49(7):1637-1646. doi:10.1007/s00125-006-0259-7

30. Michos ED, Saucier S, Mehran R, Koschinsky ML. Lipoprotein(a) and Women’s Cardiovascular Health: A Review. JACC Adv. Published online April 21, 2026:102744. doi:10.1016/j.jacadv.2026.102744

31. Komulainen P, Lakka TA, Kivipelto M, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing. 2007;36(4):443-448. doi:10.1093/ageing/afm051

32. Ebong IA, Schreiner P, Lewis CE, Appiah D, Ghelani A, Wellons M. The association between high-sensitivity C-reactive protein and hypertension in women of the CARDIA study. Menopause. 2016;23(6):662-668. doi:10.1097/GME.0000000000000609

33. Tang XX, Wu R, Chen JH, et al. Association between HOMA-IR and metabolic dysfunction-associated steatohepatitis in U.S. adults with MASLD. Metabol Open. 2025;28:100402. doi:10.1016/j.metop.2025.100402

34. Merlo F, Groothof D, Khatami F, et al. Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study. J Clin Med. 2023;12(16):5338. doi:10.3390/jcm12165338

35. Sahola N, Toffol E, Kalleinen N, Polo-Kantola P. Worse sleep architecture but not self-reported insomnia and sleepiness is associated with higher cortisol levels in menopausal women. Maturitas. 2024;187:108053. doi:10.1016/j.maturitas.2024.108053